Cargando…
EGFR突变与非小细胞肺癌放射治疗进展
Radiotherapy plays a pivotal role in the treatment for lung cancer. Epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC) which predicts tyrosine kinase inhibitor (TKI) treatment response may also has effect on radiation response. NSCLC harboring kinase-domain mutati...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015137/ https://www.ncbi.nlm.nih.gov/pubmed/23514946 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.08 |